Showing results (61-70 of 278) with videos related to

Sort By:
Pageof 28
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationMichael J Vinikoor, Anna Cope, Cynthia L Gay, et al.
AIDS (London, England)|November 14, 2025
Resistance to broadly neutralizing antibodies in perinatally infected infants from a Clade C HIV cohort in MozambiqueLesley R de Armas, Marina Tuyishime, J Shawn Justement, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Rapid viral suppression using integrase inhibitors during acute HIV-1 infectionMehri S McKellar, Jessica R Keys, Lindsey M Filiatreau, et al.
Vaccine|December 7, 2007
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adultsGeoffrey J Gorse, Lindsey R Baden, Margaret Wecker, et al.
Antiviral Therapy|April 8, 2017
Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, CameroonCatherine A Hankins, Sinata Koulla-Shiro, Peter Kilmarx, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 alleleGuido Ferrari, Wesley Neal, Janet Ottinger, et al.
AIDS Research and Human Retroviruses|October 11, 2018
Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant MacaquesAlan D Curtis, Korey A Walter, Rafiq Nabi, et al.
Frontiers in Immunology|May 7, 2020
Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® MoleculesJustin Pollara, R Whitney Edwards, Shalini Jha, et al.
The Journal of Infectious Diseases|June 2, 2011
Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccineLilin Lai, Suefen Kwa, Pamela A Kozlowski, et al.
Journal of Virology|July 22, 2016
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost ImmunizationSamantha Townsley, Zeinab Mohamed, Wenjin Guo, et al.
Pageof 28